The study was published on the occasion of the first anniversary of the Access to COVID-19 Tools (ACT) Accelerator and was launched at a commemorative event held online.
“A year after the launch of ACT Accelerator, world leaders must make a choice: invest in saving lives by addressing the cause of the pandemic everywhere now, or continue spending trillions for the consequences with no end in sight,” said the director WHO – General Tedros Adhanom Ghebreyesus.
“With a residual funding gap of $ 19 billion for 2021 and a limited supply of products, we can end the pandemic only by financing, sharing and increasing access to the tools we need to fight the disease. to ACT is now. ”
Rapid scientific progress
The ACT-Accelerator brings together governments, global health organizations, scientists, the pharmaceutical industry and other key partners, to develop and deliver the tests, treatments and vaccines the world needs to fight COVID-19.
As of Friday, there have been more than 144 million cases worldwide and over three million deaths.
A year ago, global understanding of the new disease was limited and there were no rapid diagnostic tests or vaccines. ACT-Accelerator has led to rapid scientific advancements and unprecedented global collaboration in making these tools available to anyone, anywhere, who needs them.
Saving lives, giving hope
“The ACT-Accelerator has been a key multilateral tool in responding to the COVID-19 pandemic,” UN Deputy Secretary General Amina Mohammed said in a video message.
“It’s saving lives. It allows companies and economies to start recovery work. It is giving us hope. ”
Millions of treatment courses and diagnostic kits for low- and middle-income countries, as well as $ 50 million in personal protective equipment (PPE), have been secured through the mechanism.
Its vaccine mainstay, COVAX, began deliveries to developing countries in February, starting with Ghana, and has since shipped more than 40 million doses to nearly 120 countries. Additionally, it provided $ 50 million in personal protective equipment (PPE)
Progress at risk
But WHO has said that COVID-19 continues to spread and new variants emerge, because progress on equitable distribution of these tools has not been fast enough.
Warning that “vaccine nationalism” is slowing vaccine deliveries to the world’s poorest and most vulnerable, Ms. Mohammed asked countries to fully fund the ACT-Accelerator.
“We also recognize that a comprehensive and truly sustainable recovery also requires us to get on track to achieve the Sustainable Development Goals and achieve universal health coverage,” he added.